Download PDF
doi: 10.53388/2025001
Published online: March 31, 2025
Citation: Lin XX, He Q, You SJ, Zhang XH. Progress in the study of treatment using Chinese medicine for metabolism-related fatty liver disease in children. Gastroenterol & Hepatol Res. 2025;7(1):1. doi: 10.53388/2025001.
Metabolism-associated fatty liver disease (MAFLD) is a disease of hepatic fat accumulation resulting from metabolic disorders. Currently, MAFLD is the most common cause of chronic liver disease in children and adolescents. No effective or safe drugs for treating children with MAFLD are available. The traditional Chinese medicine used for treating MAFLD in children is characterized by being holistically regulated, multileveled, multi-targeting, and very safe. In this paper, the progress in research involving treatment using traditional Chinese medicine for MAFLD in children is reviewed.
Copyright © 2025 Authors. This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 4.0 License (CC BY-NC 4.0), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.